Gauss

Ifng (human) recombinant protein 100 µg

Réf. UGAP : 3871000 Réf. Fournisseur : 16262000 Réf. Constructeur : P3982
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.
Il ne reste que 0 exemplaires.

Points clés

Used for Func, SDS-PAGE

Interferon-gamma (IFNG), or type II interferon, is a cytokine critical for innate and adaptive immunitésy against viral and intracellular bacterial infections and for tumor control. Aberrant IFNG expression is associated with a number of autoinflammatory and autoimmune diseases. The importance of IFNG in the immune system stems in part from its ability to inhibit viral replication directly, but most importantly derives from its immunostimulatory and immunomodulatory effects. IFNG is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response, and by CD4 (MIM 186940) and CD8 (see MIM 186910) cytotoxic T lymphocyte (CTL) effector T cells once antigen-specific immunitésy develops (Schoenborn and Wilson, 2007 [PubMed 17981204]).[supplied by OMIM]

En savoir plus

Garantie

Garantie 0 Mois

Description

Used for Func, SDS-PAGE

Interferon-gamma (IFNG), or type II interferon, is a cytokine critical for innate and adaptive immunitésy against viral and intracellular bacterial infections and for tumor control. Aberrant IFNG expression is associated with a number of autoinflammatory and autoimmune diseases. The importance of IFNG in the immune system stems in part from its ability to inhibit viral replication directly, but most importantly derives from its immunostimulatory and immunomodulatory effects. IFNG is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response, and by CD4 (MIM 186940) and CD8 (see MIM 186910) cytotoxic T lymphocyte (CTL) effector T cells once antigen-specific immunitésy develops (Schoenborn and Wilson, 2007 [PubMed 17981204]).[supplied by OMIM]

Caractéristiques

Fournisseur
FISHER SCIENTIFIC S.A.S.
Marque
ABNOVA
Référence fabricant
P3982
Référence distributeur
16262000
Vendu par
100 ug
Quantité
N/A
Lieu de fabrication
Taiwan
Lieu de stockage
France
Délai de péremption à la date de livraison
12 mois
Code à barre
non
Soumis à carboglace
oui
Libellé produit fabricant
100ug ifng (human) recombinant protein
Certification
RUO
Marquage CE DIV
non
Type de produit
protéine
Type de protéine
oui
Type d'antibiotique
non
Type d'enzyme
non
Température de conservation (°C)
-192 °C
Température de transport
carboglace
Dispositif stérile
non
Type d'acide nucléique extrait
non
Origine humaine
non
Sans composant animal
non
Matière dangereuse
non
Autres caractéristiques
Abnova Human IFNG (P01579, 144 amino acids) Partial Recombinant Protein, Format: Lyophilized, Formulation: Lyophilized, Host Species: Escherichia coli, Molecular Weight: 16.9kDa, Protein Tag: none, Quantity: 100 ug, Recombinant: Yes, Regulatory Statu
Classification REACH
non
Code douanier
38229000
Nomenclature Nacres
NA.55
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA55
Nomenclature CNRS
NA55
Nomenclature CHU
18.551
Nomenclature DGOS
LD10AOOO
Type d'échantillon
protéine
Type d’application
ELISA, Western-Blot
Reprise en cas d’erreur client
non
Domaine de recherche
protéomique